Dennis E Hruby - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dennis E Hruby

Showing results (61-70 of 85) with videos related to

Pageof 9

Sort By:

Journal of Virology|October 28, 2004

New class of orthopoxvirus antiviral drugs that block viral maturationChelsea M Byrd, Tové C Bolken, Adnan M Mjalli, et al.

Antiviral Research|December 22, 2012

Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®Élida Santos-Fernandes, Cristiana O Beltrame, Chelsea M Byrd, et al.

Antiviral Therapy|February 5, 2008

Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft culturesSophie Duraffour, Robert Snoeck, Rita de Vos, et al.

The American Journal of Tropical Medicine and Hygiene|April 12, 2007

Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infectionElena Sbrana, Robert Jordan, Dennis E Hruby, et al.

Antiviral Therapy|February 7, 2009

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.

The Journal of Infectious Diseases|July 9, 2018

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus MacaquesAndrew T Russo, Douglas W Grosenbach, Trevor L Brasel, et al.

Vaccine|January 30, 2008

Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus disseminationDouglas W Grosenbach, Robert Jordan, David S King, et al.

Bioorganic & Medicinal Chemistry Letters|June 6, 2012

SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activityJames R Burgeson, Amy L Moore, Jordan K Boutilier, et al.

Antimicrobial Agents and Chemotherapy|April 14, 2010

Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjectsRobert Jordan, Jarasvech Chinsangaram, Tove' C Bolken, et al.

Plos Biology|December 21, 2023

Early administration of tecovirimat shortens the time to mpox clearance in a model of human infectionBach Tran Nguyen, Aurélien Marc, Clara Suñer, et al.

Pageof 9

Search research articles

Showing results (61-70 of 85) with videos related to

Sort By:

Pageof 9

Journal of Virology|October 28, 2004

New class of orthopoxvirus antiviral drugs that block viral maturationChelsea M Byrd, Tové C Bolken, Adnan M Mjalli, et al.

Antiviral Research|December 22, 2012

Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®Élida Santos-Fernandes, Cristiana O Beltrame, Chelsea M Byrd, et al.

Antiviral Therapy|February 5, 2008

Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft culturesSophie Duraffour, Robert Snoeck, Rita de Vos, et al.

The American Journal of Tropical Medicine and Hygiene|April 12, 2007

Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infectionElena Sbrana, Robert Jordan, Dennis E Hruby, et al.

Antiviral Therapy|February 7, 2009

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.

The Journal of Infectious Diseases|July 9, 2018

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus MacaquesAndrew T Russo, Douglas W Grosenbach, Trevor L Brasel, et al.

Vaccine|January 30, 2008

Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus disseminationDouglas W Grosenbach, Robert Jordan, David S King, et al.

Bioorganic & Medicinal Chemistry Letters|June 6, 2012

SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activityJames R Burgeson, Amy L Moore, Jordan K Boutilier, et al.

Antimicrobial Agents and Chemotherapy|April 14, 2010

Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjectsRobert Jordan, Jarasvech Chinsangaram, Tove' C Bolken, et al.

Plos Biology|December 21, 2023

Early administration of tecovirimat shortens the time to mpox clearance in a model of human infectionBach Tran Nguyen, Aurélien Marc, Clara Suñer, et al.

Pageof 9